{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:50:40Z","timestamp":1776747040224,"version":"3.51.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"\n Introduction<\/jats:title>\n \n Even after a century since its discovery, Chagas disease remains a major public health concern. Benznidazole and nifurtimox are the only approved treatments, but their limited efficacy and adverse effects highlight the urgent need for new therapies. In the last decade, several phenotypic screenings performed by pharmaceuticals and academic groups revealed new promising compounds. In a previous study, we identified the\n T. cruzi<\/jats:italic>\n malic enzyme (TcME) as the molecular target for the sulfonamide TCMDC-143108, a phenotypic hit made public available through the Chagas Box collection. Indeed, we determined crystallographic structures for TcME-inhibitor complexes and synthesized new molecules with improved activity against intracellular\n T. cruzi<\/jats:italic>\n forms.\n <\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n The present study aims to evaluate the efficacy of new sulfonamides derived from TCMDC-143108 in an animal model for acute Chagas disease.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n The new sulfonamides were evaluated for TcME inhibition and activity against\n T. cruzi<\/jats:italic>\n Dm28c strain, infecting h9c2 cardiomyoblast. Active compounds progressed to ADME\n in vitro<\/jats:italic>\n assays. Promising hits were assessed for oral bioavailability.\n In vivo<\/jats:italic>\n efficacy was evaluated in infected balb\/c mice by direct parasitemia, parasite tissue burden (heart, colon, and spleen), and histopathological examination.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Compounds AC-R008, AC-M109, and AC-M110 inhibited TcME and\n T. cruzi<\/jats:italic>\n intracellular growth. AC-R008 and AC-M110 exhibited good solubility at basic pH and favorable LogD\n 7.4<\/jats:sub>\n values. AC-M110 exhibited high permeability with pH-dependent behavior in the PAMPA assay and intermediate values in the Caco-2 assay, while AC-R008 showed high permeability in both assays. However, both compounds presented short half-lives and high clearance in liver microsomal assays, consistent with extensive phase I metabolism.\n In vivo<\/jats:italic>\n , oral administration resulted in plasma concentrations up to 1\u00a0\u00b5M after 1\u00a0h. In the Chagas disease animal model, AC-R008 and AC-M110 reduced parasitemia by 50% but did not reduce tissue parasite load.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n These findings demonstrate the potential of this sulfonamide scaffold while also underscoring metabolic instability and limited systemic exposure as major challenges. Future optimization efforts will focus on structural modifications and formulation strategies to enhance pharmacokinetics and therapeutic efficacy.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fphar.2025.1709223","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:28:27Z","timestamp":1764311307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of sulfonamides targeting malic enzyme in an animal model of Chagas disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Tha\u00eds Cristina Ferreira dos","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon Borges","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Layane","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio Fredo","family":"Naciuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Gon\u00e7alves","family":"Eufr\u00e1sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Eduardo","family":"Lobo-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan Marcel","family":"Giampauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria Barbosa","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Almeida","family":"Schenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Aparecida","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur Torres","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/jps.21068","article-title":"PAMPA--critical factors for better predictions of absorption","volume":"96","author":"Avdeef","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"165658","DOI":"10.1016\/j.bbadis.2019.165658","article-title":"Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control","volume":"1866","author":"Bivona","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/17460441.2020.1806233","article-title":"Animal models of chagas disease and their translational value to drug development","volume":"15","author":"Chatelain","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.2174\/0929867325666181009152844","article-title":"NADPH producing enzymes as promising drug targets for chagas disease","volume":"26","author":"Cordeiro","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1021\/acs.jmedchem.4c02942","article-title":"Discovery and early optimization of 1H-Indole-2-carboxamides with anti-trypanosoma cruzi activity","volume":"68","author":"de Oliveira","year":"2025","journal-title":"J. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"fuad022","DOI":"10.1093\/femsre\/fuad022","article-title":"The small intestine: dining table of host-microbiota meetings","volume":"47","author":"Delbaere","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.drudis.2011.11.007","article-title":"Bridging solubility between drug discovery and development","volume":"17","author":"Di","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B10","article-title":"Product properties test guideline","volume-title":"OPPTS 830.7550 partition coefficient (n octanol\/H2O), shake flask method","author":"Epa","year":"1996"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/acsmedchemlett.0c00106","article-title":"Development of selective steroid inhibitors for the Glucose-6-Phosphate dehydrogenase from Trypanosoma Cruzi","volume":"11","author":"Fredo Naciuk","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1091581815622442","article-title":"Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility","volume":"35","author":"Gad","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ddtec.2004.11.013","article-title":"Advances in screening for membrane permeability: high resolution PAMPA for medicinal chemists","volume":"1","author":"Kansy","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"B15","volume-title":"Drug-like properties: concepts, structure design and methods","author":"Kerns","year":"2008"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1005058","DOI":"10.1371\/journal.ppat.1005058","article-title":"Utilizing chemical genomics to identify cytochrome b as a novel drug target for chagas disease","volume":"11","author":"Khare","year":"2015","journal-title":"PLoS Pathog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11095-025-03850-2","article-title":"Predicting distribution coefficients (LogD) of cyclic peptides using molecular dynamics simulations","volume":"42","author":"Lou","year":"2025","journal-title":"Pharm. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1021\/acsinfecdis.1c00231","article-title":"Trypanosoma cruzi malic enzyme is the target for sulfonamide hits from the GSK chagas box","volume":"7","author":"Mercaldi","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/17460441.2024.2349155","article-title":"New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of chagas disease","volume":"19","author":"Murta","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/s0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"B22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1201\/9780429131967-7","article-title":"In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs (reaction phenotyping) with emphasis on cytochrome P450","author":"Ogilvie","year":"2008","journal-title":"Drug-drug Interactions"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1177\/2472555217706649","article-title":"Identification of specific inhibitors of Trypanosoma cruzi malic enzyme isoforms by target-based HTS","volume":"22","author":"Ranzani","year":"2017","journal-title":"SLAS Discov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106920","DOI":"10.1016\/j.actatropica.2023.106920","article-title":"Effectiveness of the repurposed drug isotretinoin in an experimental murine model of chagas disease","volume":"242","author":"Rial","year":"2023","journal-title":"Acta Trop."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e240057","DOI":"10.1590\/0074-02760240057","article-title":"Drug screening and development cascade for chagas disease: an update of in vitro and in vivo experimental models","volume":"119","author":"Soeiro","year":"2024","journal-title":"Mem\u00f3rias Do Inst. Oswaldo Cruz"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.bmc.2016.12.049","article-title":"Highly predictive and interpretable models for PAMPA permeability","volume":"25","author":"Sun","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"B28","unstructured":"Chagas disease (American trypanosomiasis)\n \n \n 2024"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1709223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:28:31Z","timestamp":1764311311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1709223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":28,"alternative-id":["10.3389\/fphar.2025.1709223"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1709223","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1709223"}}